Advanced NSCLC Clinical Trials in Nanchang, Jiangxi
4 recruitingNanchang, Jiangxi, China
Showing 1–4 of 4 trials
Recruiting
Not Applicable
Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment
Advanced NSCLC
The First Affiliated Hospital of Nanchang University10 enrolled2 locationsNCT06752044
Recruiting
Phase 2
Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment
Advanced NSCLC
The First Affiliated Hospital of Nanchang University10 enrolled2 locationsNCT06751849
Recruiting
Phase 2
Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment
Advanced NSCLC
The First Affiliated Hospital of Nanchang University10 enrolled2 locationsNCT06751901
Recruiting
Not Applicable
Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment
Advanced NSCLC
The First Affiliated Hospital of Nanchang University10 enrolled2 locationsNCT06752057